MarketResearchReport2021

Human Genetics Market Human genetics is the broad field of studying human inheritance and comprises sub-sections such as cytogenetics, molecular genetics, genetic counseling, clinical genetics, and others. It helps to understand gene functionalities and the consequences of abnormalities in them. Through human genetics, the human genome is studied to diagnose genetic disorders and provide related treatment much more efficiently. The global human genetics market is expected to have a market value of USD 60,821.20 million by 2030 . The growth of human genetics is driven by the growing adoption of genetic testing. However, high cost of genetic testing is likely to restrain the market growth.   Key Findings of the Study US accounted for the largest share of the global human genetics market due to the increasing demand for genetic testing by the population are driving the market in the region. For instance, according to Healthline Media (US), in October 2019, United HealthCare Servi

Human Genetics Market Human genetics is the broad field of studying human inheritance and comprises sub-sections such as cytogenetics, molecular genetics, genetic counseling, clinical genetics, and others. It helps to understand gene functionalities and the consequences of abnormalities in them. Through human genetics, the human genome is studied to diagnose genetic disorders and provide related treatment much more efficiently. The global human genetics market is expected to have a market value of USD 60,821.20 million by 2030 . The growth of human genetics is driven by the growing adoption of genetic testing. However, high cost of genetic testing is likely to restrain the market growth.   Major Key Players: MRFR recognizes Human Genetics Market Players are— Myriad Genetics (US), Synlab Group (Germany), Eurofins Megalab S.A (Spain), Biomarker Technology (US), Echevarne Laboratory (Spain), Elabscience Biotechnology Inc (US), NIMGenetics (Spain), Sistemas Genómicos (Spain), F